Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-10
2007-04-10
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S351000, C546S255000, C546S300000
Reexamination Certificate
active
10866078
ABSTRACT:
Novel VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones and their use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are selected.
REFERENCES:
patent: 6548548 (2003-04-01), Campbell et al.
patent: 2004/0039019 (2004-02-01), Huth et al.
patent: 2004/0102441 (2004-05-01), Krueger et al.
patent: 10023486 (2002-03-01), None
patent: 10228090 (2004-01-01), None
patent: WO 0027819 (2000-05-01), None
patent: WO 0027820 (2000-05-01), None
patent: WO 02090352 (2002-11-01), None
patent: WO 03040102 (2003-05-01), None
Bohlmann Rolf
Haberey Martin
Hess-Stumpp Holger
Huth Andreas
Ince Stuart
Davis Zinna N.
Millen White Zelano & Branigan P.C.
Schering AG
LandOfFree
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3746421